Статті в журналах з теми "Anti-TB Therapy"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Anti-TB Therapy".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Ye, L., L. Wu, J. Tang, R. Mao, and Q. Cao. "P502 Different presentation of tuberculosis associated with anti-TNF therapy among patients with Inflammatory Bowel Disease in endemic area: observation from China." Journal of Crohn's and Colitis 16, Supplement_1 (January 1, 2022): i464. http://dx.doi.org/10.1093/ecco-jcc/jjab232.629.
Повний текст джерелаMandic, Dragana, Radmila Curcic, Gordana Radosavljevic, Nemanja Damjanov, Dusan Stefanovic, Igor Mitic, and Aleksandar Dimic. "Recommendations for tuberculosis screening before and during treatment with tumour necrosis factor inhibitors." Srpski arhiv za celokupno lekarstvo 137, no. 3-4 (2009): 211–16. http://dx.doi.org/10.2298/sarh0904211m.
Повний текст джерелаMazlun, Muhamad Harith, Siti Fatimah Sabran, Maryati Mohamed, Mohd Fadzelly Abu Bakar, and Zunoliza Abdullah. "Phenolic Compounds as Promising Drug Candidates in Tuberculosis Therapy." Molecules 24, no. 13 (July 4, 2019): 2449. http://dx.doi.org/10.3390/molecules24132449.
Повний текст джерелаIbrahim, Chandra Satria. "Anti-TB Drug for Tuberculosis Spondylitis." Neurologico Spinale Medico Chirurgico 1, no. 2 (August 7, 2018): 18. http://dx.doi.org/10.15562/nsmc.v1i2.96.
Повний текст джерелаNoguera-Julian, Antoni, Joan Calzada-Hernández, Folke Brinkmann, Robindra Basu Roy, Olga Bilogortseva, Michael Buettcher, Isabel Carvalho та ін. "Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-ɑ Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) Study". Clinical Infectious Diseases 71, № 10 (4 грудня 2019): 2561–69. http://dx.doi.org/10.1093/cid/ciz1138.
Повний текст джерелаKumar, P., S. K. Vuyyuru, B. Kante, P. Sahu, S. Goyal, D. Madhu, S. Jain, et al. "P531 Stringent screening strategy significantly reduces reactivation rate of Tuberculosis in Patients with Inflammatory Bowel Disease on anti-TNF therapy in a TB endemic region." Journal of Crohn's and Colitis 16, Supplement_1 (January 1, 2022): i484. http://dx.doi.org/10.1093/ecco-jcc/jjab232.658.
Повний текст джерелаPaz, M. E. Pinto, L. Bueno Lazo, D. Carrera Palao, D. F. Pinto Ruiz, M. R. Huaman, and A. M. Quispe. "Efficacy and safety of oncoplastic surgery plus drug therapy for chronic tuberculous granulomatous mastitis." International Journal of Tuberculosis and Lung Disease 24, no. 6 (June 1, 2020): 585–90. http://dx.doi.org/10.5588/ijtld.19.0478.
Повний текст джерелаSugiyama, Yuya, Nobuhiro Ueno, Shion Tachibana, Yu Kobayashi, Yuki Murakami, Takahiro Sasaki, Aki Sakatani, et al. "The safety of vedolizumab in a patient with Crohn’s disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report." Medicine 102, no. 28 (July 14, 2023): e34331. http://dx.doi.org/10.1097/md.0000000000034331.
Повний текст джерелаHidayat, Edi Yanuarto, Nasirun Zulqarnain, and Muchlis Achsan Udji Sofro. "Perbandingan Gambaran Foto Toraks Pasien TB-HIV Dua dan Enam Bulan Pengobatan Anti-Tuberkulosis + Anti-Retroviral." Jurnal Radiologi Indonesia 1, no. 2 (September 1, 2015): 91–98. http://dx.doi.org/10.33748/jradidn.v1i2.12.
Повний текст джерелаFrolova, K. S., and S. E. Borisov. "RISK OF DEVELOPING ACTIVE TB IN IBD PATIENTS TREATED WITH ATNI-TNF." Koloproktologia, no. 1 (March 30, 2018): 49–56. http://dx.doi.org/10.33878/2073-7556-2018-0-1-49-56.
Повний текст джерелаYoo, Jung-Wan, Kyung-Wook Jo, Bo-Hyung Kang, Mi Young Kim, Bin Yoo, Chang-Keun Lee, Yong-Gil Kim та ін. "Mycobacterial diseases developed during anti-tumour necrosis factor-α therapy". European Respiratory Journal 44, № 5 (7 серпня 2014): 1289–95. http://dx.doi.org/10.1183/09031936.00063514.
Повний текст джерелаMaarman, Gerald` J. "Could melatonin be an adjunct therapy for post-TB lung disease?" Melatonin Research 4, no. 3 (September 30, 2021): 431–39. http://dx.doi.org/10.32794/mr112500103.
Повний текст джерелаTan, J., N. Hejazifar, E. Vantomme, and K. Tsoi. "A175 RECURRENT GASTROINTESTINAL BLEED – A LATE MANIFESTATION OF COLONIC TUBERCULOSIS TREATED CONSERVATIVELY." Journal of the Canadian Association of Gastroenterology 3, Supplement_1 (February 2020): 41–42. http://dx.doi.org/10.1093/jcag/gwz047.174.
Повний текст джерелаOshima, M., A. Fukui, and Y. Takakura. "A CASE OF TUBERCULOUS TENOSYNOVITIS IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS." Hand Surgery 09, no. 01 (July 2004): 109–13. http://dx.doi.org/10.1142/s0218810404002042.
Повний текст джерелаKim, Minji Jennifer, Nicholas Jones, and Laura R. Steeples. "Miliary tuberculosis developing during adalimumab treatment for Behçet’s disease with uveitis." BMJ Case Reports 11, no. 1 (December 2018): e226772. http://dx.doi.org/10.1136/bcr-2018-226772.
Повний текст джерелаHuang, Xiaojing, Xiao Zheng, and Chenyang Shen. "Antiviral Therapy with Entecavir following Antituberculosis Therapy Alleviates Liver Injury and Restores Innate Immunity in Tuberculosis Patients Coinfected with Hepatitis B Virus." Evidence-Based Complementary and Alternative Medicine 2021 (November 2, 2021): 1–8. http://dx.doi.org/10.1155/2021/2884151.
Повний текст джерелаProsvetov, Yu V., A. Yu Gusarova, S. S. Barinov, and A. V. Husarova. "CORRECTION OF SOME SIDE EFFECTS TO ANTI-TUBERCULOSIS THERAPY IN MODERN CONDITIONS." Modern medical technology, no. 2(53) (June 10, 2022): 19–25. http://dx.doi.org/10.34287/mmt.2(53).2022.4.
Повний текст джерелаZeller, Michelle P., Jan H. Beumer, Susan M. Christner, and Anargyros Xenocostas. "Pharmacokinetics of Dasatinib in a Patient with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During Treatment with Anti-Tuberculosis Therapy." Blood 118, no. 21 (November 18, 2011): 5006. http://dx.doi.org/10.1182/blood.v118.21.5006.5006.
Повний текст джерелаNasser, Abdullah Al Shekeili, Muhammad Tareq Khan Yaseer, and Ismail Mousa Tia Khalid. "Use of Corticosteroid as an Adjunct with Antitubercular Therapy in the Management of Miliary Tuberculosis Associated with Organizing PneumoniaA Case Report." Journal of Clinical Cases & Reports 2, no. 1 (January 31, 2019): 5–11. http://dx.doi.org/10.46619/joccr.2019.2-1029.
Повний текст джерелаSingh, Dhiraj Kumar, Sultan Tousif, Ashima Bhaskar, Annu Devi, Kriti Negi, Barnani Moitra, Anand Ranganathan, Ved Prakash Dwivedi, and Gobardhan Das. "Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis." PLOS Pathogens 17, no. 8 (August 20, 2021): e1009805. http://dx.doi.org/10.1371/journal.ppat.1009805.
Повний текст джерелаMdivani, Nino, Haijing Li, Maka Akhalaia, Medea Gegia, Leila Goginashvili, Douglas S. Kernodle, George Khechinashvili, and Yi-Wei Tang. "Monitoring Therapeutic Efficacy by Real-Time Detection of Mycobacterium tuberculosis mRNA in Sputum." Clinical Chemistry 55, no. 9 (September 1, 2009): 1694–700. http://dx.doi.org/10.1373/clinchem.2009.124396.
Повний текст джерелаRibeiro-Rodrigues, Rodrigo, Tatiana Resende Co, John L. Johnson, Fabiola Ribeiro, Moises Palaci, Ricardo T. Sá, Ethel L. Maciel, et al. "Sputum Cytokine Levels in Patients with Pulmonary Tuberculosis as Early Markers of Mycobacterial Clearance." Clinical and Vaccine Immunology 9, no. 4 (July 2002): 818–23. http://dx.doi.org/10.1128/cdli.9.4.818-823.2002.
Повний текст джерелаTodoriko, L. D., О. V. Pidverbetska, І. О. Semianiv, І. V. Yeremenchuk, and М. М. Kuzhko. "Applications of infusion therapy in the difficult form of tuberculosis." Infusion & Chemotherapy, no. 3.1 (October 11, 2020): 77. http://dx.doi.org/10.32902/2663-0338-2020-3.1-64.
Повний текст джерелаAlghamdi, Wael A., Sampson Antwi, Anthony Enimil, Hongmei Yang, Albert Dompreh, Lubbe Wiesner, Taimour Langaee, Charles A. Peloquin, and Awewura Kwara. "Population pharmacokinetics of efavirenz in HIV and TB/HIV coinfected children: the significance of genotype-guided dosing." Journal of Antimicrobial Chemotherapy 74, no. 9 (June 26, 2019): 2698–706. http://dx.doi.org/10.1093/jac/dkz238.
Повний текст джерелаSubhash, H. S., I. Ashwin, U. Mukundan, D. Danda, G. John, A. M. Cherian, and K. Thomas. "Drug Resistant Tuberculosis in Diabetes Mellitus: A Retrospective Study from South India." Tropical Doctor 33, no. 3 (July 2003): 154–56. http://dx.doi.org/10.1177/004947550303300311.
Повний текст джерелаP. R., Shreenivas, and S. Nagaraja Prasad. "Study of price variation among the different brands of anti-tubercular drugs available in India." International Journal of Basic & Clinical Pharmacology 6, no. 3 (February 24, 2017): 660. http://dx.doi.org/10.18203/2319-2003.ijbcp20170832.
Повний текст джерелаA, Vijayalakshmi, Thanmayi G, and Jayakumari S. "A PROSPECTIVE STUDY ON ABNORMAL LFT PATTERNS IN PATIENTS RECEIVING ANTITUBERCULOSIS THERAPY." Asian Journal of Pharmaceutical and Clinical Research 9, no. 5 (September 1, 2016): 136. http://dx.doi.org/10.22159/ajpcr.2016.v9i5.12756.
Повний текст джерелаDas, Priya, Asesh Banerjee, and Dr Prithviraj Karak. "Molecular Interplay between Vitamin D and Immunity can Aid Antitubercular Treatment Vitamin D in Immunomodulation of TB." Defence Life Science Journal 7, no. 3 (September 13, 2022): 209–20. http://dx.doi.org/10.14429/dlsj.7.17566.
Повний текст джерелаDavarpanah, Mohammad Ali, and Seyed Mohammad Hoseini. "Incidence of Active Tuberculosis Among Human Immunodeficiency Virus (HIV)-Positive Patients and Evaluation of Their Responses to Usual Anti-Tuberculosis Medications in Shiraz, South West of Iran." Galen Medical Journal 4, no. 2 (March 21, 2015): 115–20. http://dx.doi.org/10.31661/gmj.v4i2.260.
Повний текст джерелаRawal, Gautam, Sankalp Yadav, and Sujana Rajamma. "Myocardial tuberculosis: A rare case report." Discussion of Clinical Cases 9, no. 2 (March 6, 2023): 13. http://dx.doi.org/10.5430/dcc.v9n2p13.
Повний текст джерелаSaid, Bibie, Edwin Nuwagira, Alphonce Liyoyo, Rinah Arinaitwe, Catherine Gitige, Rhina Mushagara, Peter Buzaare, et al. "Early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa: a protocol of a randomised clinical trial." BMJ Open 12, no. 6 (June 2022): e061953. http://dx.doi.org/10.1136/bmjopen-2022-061953.
Повний текст джерелаTao, Lina, Xiaoyu Qu, Yue Zhang, Yanqing Song, and Si-xi Zhang. "Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials." Canadian Journal of Gastroenterology and Hepatology 2019 (January 10, 2019): 1–11. http://dx.doi.org/10.1155/2019/3192351.
Повний текст джерелаRaymond E Eworo, Augusta C Nsonwu-Anyanwu, Unyime A Fabian, Patience A Akpan, and Peace E Udo. "Nutritional background of low-income pulmonary tuberculosis patients on anti-tuberculosis therapy at Infectious Disease Hospital, Calabar, Nigeria: A case-control study." Open Access Research Journal of Science and Technology 5, no. 1 (July 30, 2022): 070–79. http://dx.doi.org/10.53022/oarjst.2022.5.1.0044.
Повний текст джерелаKhadka, Anjan. "BEDAQUILINE: A long but much fruitful wait since seventies." Medical Journal of Shree Birendra Hospital 13, no. 1 (July 19, 2015): 40–42. http://dx.doi.org/10.3126/mjsbh.v13i1.13000.
Повний текст джерелаEsmael, Ahmed, Adane Mihret, Tamrat Abebe, Daniel Mussa, Sebsibe Neway, Joel Ernst, Jyothi Rengarajan, Liya Wassie, and Rawleigh Howe. "Persistent expression of activation markers on Mycobacterium tuberculosis-specific CD4 T cells in smear negative TB patients." PLOS ONE 17, no. 8 (August 30, 2022): e0271234. http://dx.doi.org/10.1371/journal.pone.0271234.
Повний текст джерелаGarfein, R. S., L. Liu, J. Cuevas-Mota, K. Collins, D. G. Catanzaro, F. Muñoz, K. Moser, et al. "Evaluation of recorded video-observed therapy for anti-tuberculosis treatment." International Journal of Tuberculosis and Lung Disease 24, no. 5 (May 1, 2020): 520–25. http://dx.doi.org/10.5588/ijtld.19.0456.
Повний текст джерелаAdeniji, Adetomiwa A., Kirsten E. Knoll, and Du Toit Loots. "Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus." Applied Microbiology and Biotechnology 104, no. 13 (May 5, 2020): 5633–62. http://dx.doi.org/10.1007/s00253-020-10606-y.
Повний текст джерелаSutanto, Yusup Subagio, Magdalena Sutanto Sutanto, and Agnes Sri Harti. "Anti-Tuberculosis Drugs against the Resistance Level of Mycobacterium tuberculosis isolates." Jurnal Kesehatan Masyarakat 17, no. 1 (July 24, 2021): 14–23. http://dx.doi.org/10.15294/kemas.v17i1.24158.
Повний текст джерелаTang, Peijun, Xingnian Chen, Junchi Xu, Yunlong Hu, Zhijian Ye, Xiafang Wang, Yumei Xiao, et al. "Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis." Journal of Immunology Research 2022 (March 17, 2022): 1–10. http://dx.doi.org/10.1155/2022/2943113.
Повний текст джерелаShevchenko, Olha S., Liliia D. Todoriko, Olha O. Pohorelova, Ihor O. Semianiv, Irina A. Ovcharenko, Rostislav S. Shevchenko, Stanislav I. Shevchenko, Inga V. Yeremenchuk, Olena V. Pidverbetska, and Yana I. Toderika. "FUNCTIONAL STATE OF THE LIVER IN PULMONARY TUBERCULOSIS IN THE DYNAMICS OF PATHOGENETIC TREATMENT WITH A COMPLEX OF AMINO ACIDS." Wiadomości Lekarskie 76, no. 2 (2023): 352–59. http://dx.doi.org/10.36740/wlek202302116.
Повний текст джерелаAbdulaziz, S., S. Attar, W. Bajhammoh, E. A. Sindi, D. M. Ayish, and E. Bakhashwain. "POS1153 EFFECTIVENESS OF SCREENING IN PATIENTS WITH RHEUMATIC DISEASE ON BIOLOGICAL THERAPY AND RISK OF ACTIVE TUBERCULOSIS." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 855.1–856. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1617.
Повний текст джерелаKale, Monali Raghunath, Mirza Shiraz Baig, and Avinash Lamb. "A prospective observational pharmacovigilance study of adverse drug reaction monitoring in patients of tuberculosis receiving category I and II treatment regimens at tertiary care hospital." International Journal of Basic & Clinical Pharmacology 8, no. 5 (April 23, 2019): 875. http://dx.doi.org/10.18203/2319-2003.ijbcp20191568.
Повний текст джерелаMuhammad, N., S. Mehboob, and M. Abbas. "Pyrazinamide Induced Hyperuricemia in the Induction Phase of Anti-Tuberculosis Therapy." Pakistan Journal of Medical and Health Sciences 15, no. 5 (May 30, 2021): 1136–38. http://dx.doi.org/10.53350/pjmhs211551136.
Повний текст джерелаGoovaerts, Odin, Marguerite Massinga-Loembé, Pascale Ondoa, Ann Ceulemans, William Worodria, Harriet Mayanja-Kizza, Robert Colebunders, and Luc Kestens. "Lack of elevated pre-ART elastase-ANCA levels in patients developing TB-IRIS." PLOS ONE 15, no. 12 (December 31, 2020): e0244800. http://dx.doi.org/10.1371/journal.pone.0244800.
Повний текст джерелаXi, Ying, Wei Zhang, Rui-Jun Qiao, and Jun Tang. "Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis." PLOS ONE 17, no. 6 (June 16, 2022): e0270003. http://dx.doi.org/10.1371/journal.pone.0270003.
Повний текст джерелаLancella, Laura, Luciana Abate, Laura Cursi, Giulia Chiopris, Laura Nicoletti, Nicola Principi, Alberto Villani, and Susanna Esposito. "Abdominal Tuberculosis in Children: A Case Series of Five Patients." Microorganisms 11, no. 3 (March 12, 2023): 730. http://dx.doi.org/10.3390/microorganisms11030730.
Повний текст джерелаLozovskaya, Marina E., Yulia A. Yarovaya, Elena B. Vasilieva, Ludmila V. Klochkova, Elena A. Malysheva, and Olga M. Noskova. "Combination of tuberculosis of the intra thoracic lymph nodes and acute lymphoblastic leukemia in a child." Pediatrician (St. Petersburg) 12, no. 6 (April 18, 2022): 89–96. http://dx.doi.org/10.17816/ped12689-96.
Повний текст джерелаDutta, Noton K., Natalie Bruiners, Matthew D. Zimmerman, Shumin Tan, Véronique Dartois, Maria L. Gennaro, and Petros C. Karakousis. "Adjunctive Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes in Mice." Journal of Infectious Diseases 221, no. 7 (October 12, 2019): 1079–87. http://dx.doi.org/10.1093/infdis/jiz517.
Повний текст джерелаKaushal, Deepak, Dhiraj K. Singh, and Smriti Mehra. "Immune Responses in Lung Granulomas during Mtb/HIV Co-Infection: Implications for Pathogenesis and Therapy." Pathogens 12, no. 9 (September 1, 2023): 1120. http://dx.doi.org/10.3390/pathogens12091120.
Повний текст джерелаNovikov, Vasiliy E., Natalia E. Usacheva, and Tatyana V. Myakisheva. "Modern approaches to pharmacotherapy of tuberculosis infection in children." Research Results in Pharmacology 7, no. 4 (December 3, 2021): 47–53. http://dx.doi.org/10.3897/rrpharmacology.7.66627.
Повний текст джерела